Search

everythinglearnresearchcommunity

for

Search:↓

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Plucked hair follicles can help diagnose scalp lupus.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

PCOS involves genetic and immune factors, especially T cells, affecting its development.

Talc in street cocaine can cause immune-reactive skin nodules where injected.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss in Discoid Lupus.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

ILC1-like cells may contribute to hair loss in alopecia areata.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.